use the UK’s strong biosciences research and life sciences industrial base
enhance the international competitiveness of our life sciences industry
The government’s response sets out how government will work with industry and the health system to create an approvals system so that cost-effective breakthrough products can get to NHS patients as fast as possible.
This response includes:
an ‘accelerated access collaborative’ to bring breakthrough products to market and then to patients as quickly as possible
£86 million of government funding to support innovators and the NHS in overcoming barriers to getting new, innovative technologies to patients quickly
improved NHS England commercial capacity and capability to deliver deals that achieve better value for the NHS and innovators